Novacyt
ALNOV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010397232 (+1 more)
- LEI:
- 213800BWAC2BF295EG28
- Country:
- France
- Address:
- 13 AVENUE MORANE SAULNIER, 78129 VELIZY-VILLACOUBLAY
- Website:
- https://novacyt.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Novacyt is an international molecular diagnostics company specializing in the design, manufacture, and global supply of in vitro and molecular diagnostic tests. The company provides a broad portfolio of integrated technologies, services, assays, and reagents, with a primary focus on genomic medicine. Its products serve a wide range of applications, including infectious diseases and oncology. Through its specialized business units, such as Primerdesign, Novacyt delivers real-time PCR kits and custom development solutions to a global customer base in human health, food safety, and veterinary diagnostics.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Novacyt.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-01 17:02 |
Declaration of Voting Results & Voting Rights Announcements
Liquidity Agreement Monthly Update & TVR
|
English | 23.7 KB | |
| 2025-08-01 16:00 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
|
French | 241.0 KB | |
| 2025-07-29 08:00 |
Interim Report
Half-year trading update
|
English | 25.1 KB | |
| 2025-07-15 08:00 |
Regulatory News Service
Launch of LightBench® Discover
|
English | 23.5 KB | |
| 2025-07-15 07:00 |
Regulatory News Service
Lancement de LightBench® Discover
|
French | 247.4 KB | |
| 2025-07-01 14:45 |
Transaction in Own Shares
Liquidity Agreement Monthly Update and TVR
|
English | 23.7 KB | |
| 2025-06-20 07:00 |
Post-Annual General Meeting Information
Résultat de l’Assemblée Générale Annuelle (AGA)
|
French | 244.2 KB | |
| 2025-06-16 07:00 |
Report Publication Announcement
Publication du rapport annuel
|
French | 215.8 KB | |
| 2025-06-02 12:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
|
French | 221.3 KB | |
| 2025-05-02 12:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
|
French | 220.2 KB | |
| 2025-04-30 07:00 |
Annual Report
Résultats de l'année 2024
|
French | 1.1 MB | |
| 2025-04-22 07:00 |
Report Publication Announcement
Avis sur les résultats
|
French | 211.6 KB | |
| 2025-04-01 12:45 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
|
French | 217.6 KB | |
| 2025-03-18 18:00 |
Legal Proceedings Report
Mise à jour relative aux poursuites judiciaires lancées contre Lab 21 par le He…
|
French | 218.7 KB | |
| 2025-03-18 17:15 |
Legal Proceedings Report
Update re. Lab 21 HSE Prosecution
|
English | 20.2 KB |
Automate Your Workflow. Get a real-time feed of all Novacyt filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Novacyt via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
